Screener
DaVita DVA U.S.Dialysis — Acquisitions
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by DaVita in its filing.
Tagged under the XBRL concept us-gaap:GoodwillAcquiredDuringPeriod.
The source filing: DaVita’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 5:03 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000927066-26-000062
| Line item | U.S. dialysis | Other — Ancillary services | Consolidated |
|---|---|---|---|
| Acquisitions | 10,396 | 61,288 | 71,684 |
| Foreign currency and other adjustments | — | 98,195 | 98,195 |
| Balance at December 31, 2025 | 6,527,616 | 1,017,479 | 7,545,095 |
| Acquisitions | 21,098 | 9,542 | 30,640 |
| Foreign currency and other adjustments | — | 6,578 | 6,578 |
| Balance at March 31, 2026 | $6,548,714 | $1,033,599 | $7,582,313 |
| Balance at March 31, 2026: | |||
| Goodwill | $6,548,714 | $1,187,860 | $7,736,574 |
Item 1. Condensed Consolidated Financial Statements:
FAQ
- What is DaVita's u.s.dialysis — acquisitions?
- DaVita (DVA) reported u.s.dialysis — acquisitions of $21.1M in Q1 2026.
- What does u.s.dialysis — acquisitions mean?
- Captures the capital expenditure or cash outflow dedicated to acquiring additional dialysis clinics or related healthcare assets within the U.S. market. This metric tracks the firm's inorganic growth strategy and expansion of its clinical footprint. It serves as a primary indicator of the company's commitment to increasing market share through consolidation.
Ask your AI about DaVita's u.s.dialysis — acquisitions.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude